Production (Stage)
NanoViricides, Inc.
NNVC
$1.54
$0.053.36%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 58.21% | 43.83% | 20.69% | 9.30% | 9.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.82% | 3.20% | -4.78% | 38.83% | 37.89% |
| Operating Income | 1.82% | -3.20% | 4.78% | -38.83% | -37.89% |
| Income Before Tax | -0.09% | -5.18% | 3.43% | -39.86% | -35.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.09% | -5.18% | 3.43% | -39.86% | -35.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.09% | -5.18% | 3.43% | -39.86% | -35.83% |
| EBIT | 1.82% | -3.20% | 4.78% | -38.83% | -37.89% |
| EBITDA | 2.16% | -3.34% | 5.36% | -43.25% | -42.09% |
| EPS Basic | 10.42% | 1.64% | 5.43% | -38.46% | -34.50% |
| Normalized Basic EPS | 10.40% | 1.64% | 5.44% | -38.40% | -34.46% |
| EPS Diluted | 10.42% | 1.64% | 5.43% | -38.46% | -34.50% |
| Normalized Diluted EPS | 10.40% | 1.64% | 5.44% | -38.40% | -34.46% |
| Average Basic Shares Outstanding | 11.85% | 6.11% | 2.11% | 1.11% | 1.01% |
| Average Diluted Shares Outstanding | 11.85% | 6.11% | 2.11% | 1.11% | 1.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |